• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall VersaTREK Myco AS.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 3 Device Recall VersaTREK Myco AS. see related information
Date Initiated by Firm August 08, 2005
Date Posted September 14, 2005
Recall Status1 Terminated 3 on July 21, 2007
Recall Number Z-1540-05
Recall Event ID 33135
Product Classification System, Blood Culturing - Product Code MDB
Product VersaTREK Myco AS.
Code Information lot code 144365, expiration date 2005/11.
Recalling Firm/
Manufacturer
Trek Diagnostic Systems
982 Keynote Cir Ste 6
Cleveland OH 44131-1873
For Additional Information Contact Teresa Anacker
800-642-7029
Manufacturer Reason
for Recall
Invitro diagnostic test kit used for testing to confirm the presence of tuberculosis contains interfering bioburden which can cause false positive results.
FDA Determined
Cause 2
Other
Action The recalling firm phoned all 13 consignees that the product was distributed to, and sent a recall letter to all 13 consignees, dated August 8, 2005. All 13 consignees have responded back to the recalling firm and have discarded any remaining product that was on hand.
Quantity in Commerce 29 boxes containing 5 vials in each box.
Distribution The product was distributed to consignees located in AL, IA, IL, MD, NJ, OH, PA, Washington D.C. and to two foreign distributors: I.L. Diagnostics, Lago Victoria No. 80, Col. Granada, Mexico D.F., 11520; and Trivitron Diagnostics, #15 4th Street, Abhiramapuram, Chennai, India 600-018.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-